217 related articles for article (PubMed ID: 36960846)
1. Atopic dermatitis - Perspectives and unmet medical needs.
Buhl T; Werfel T
J Dtsch Dermatol Ges; 2023 Apr; 21(4):349-353. PubMed ID: 36960846
[TBL] [Abstract][Full Text] [Related]
2. IL-13 antagonists in the treatment of atopic dermatitis.
Tubau C; Puig L
Immunotherapy; 2021 Mar; 13(4):327-344. PubMed ID: 33430628
[TBL] [Abstract][Full Text] [Related]
3. Novel topical and systemic therapies in atopic dermatitis.
Suga H; Sato S
Immunol Med; 2019 Jun; 42(2):84-93. PubMed ID: 31318324
[TBL] [Abstract][Full Text] [Related]
4. Janus kinase inhibitors for atopic dermatitis: a promising treatment modality.
Cartron AM; Nguyen TH; Roh YS; Kwatra MM; Kwatra SG
Clin Exp Dermatol; 2021 Jul; 46(5):820-824. PubMed ID: 33484582
[TBL] [Abstract][Full Text] [Related]
5. Emerging therapies for atopic dermatitis: JAK inhibitors.
Cotter DG; Schairer D; Eichenfield L
J Am Acad Dermatol; 2018 Mar; 78(3 Suppl 1):S53-S62. PubMed ID: 29248518
[TBL] [Abstract][Full Text] [Related]
6. JAK/STAT inhibitors for the treatment of atopic dermatitis.
Rodrigues MA; Torres T
J Dermatolog Treat; 2020 Feb; 31(1):33-40. PubMed ID: 30703333
[No Abstract] [Full Text] [Related]
7. Adult atopic dermatitis: new and emerging therapies.
Napolitano M; Marasca C; Fabbrocini G; Patruno C
Expert Rev Clin Pharmacol; 2018 Sep; 11(9):867-878. PubMed ID: 30073901
[TBL] [Abstract][Full Text] [Related]
8. Innovation in Atopic Dermatitis: From Pathogenesis to Treatment.
Munera-Campos M; Carrascosa JM
Actas Dermosifiliogr (Engl Ed); 2020 Apr; 111(3):205-221. PubMed ID: 31964499
[TBL] [Abstract][Full Text] [Related]
9. JAK Inhibitors for Atopic Dermatitis: An Update.
He H; Guttman-Yassky E
Am J Clin Dermatol; 2019 Apr; 20(2):181-192. PubMed ID: 30536048
[TBL] [Abstract][Full Text] [Related]
10. JAK inhibitors in the treatment of atopic dermatitis.
Chovatiya R; Paller AS
J Allergy Clin Immunol; 2021 Oct; 148(4):927-940. PubMed ID: 34437922
[TBL] [Abstract][Full Text] [Related]
11. Innovation in the treatment of atopic dermatitis: Emerging topical and oral Janus kinase inhibitors.
Nakashima C; Yanagihara S; Otsuka A
Allergol Int; 2022 Jan; 71(1):40-46. PubMed ID: 34815171
[TBL] [Abstract][Full Text] [Related]
12. Oral Janus kinase inhibitors for atopic dermatitis.
Mikhaylov D; Ungar B; Renert-Yuval Y; Guttman-Yassky E
Ann Allergy Asthma Immunol; 2023 May; 130(5):577-592. PubMed ID: 36736457
[TBL] [Abstract][Full Text] [Related]
13. [New aspects in systemic treatment of atopic dermatitis].
Werfel T; Wollenberg A; Pumnea T; Heratizadeh A
Hautarzt; 2018 Mar; 69(3):217-224. PubMed ID: 29470609
[TBL] [Abstract][Full Text] [Related]
14. Safety and efficacy of upadacitinib in combination with topical corticosteroids in adolescents and adults with moderate-to-severe atopic dermatitis (AD Up): results from a randomised, double-blind, placebo-controlled, phase 3 trial.
Reich K; Teixeira HD; de Bruin-Weller M; Bieber T; Soong W; Kabashima K; Werfel T; Zeng J; Huang X; Hu X; Hendrickson BA; Ladizinski B; Chu AD; Silverberg JI
Lancet; 2021 Jun; 397(10290):2169-2181. PubMed ID: 34023009
[TBL] [Abstract][Full Text] [Related]
15. Treatments for Childhood Atopic Dermatitis: an Update on Emerging Therapies.
Chu CY
Clin Rev Allergy Immunol; 2021 Oct; 61(2):114-127. PubMed ID: 32607924
[TBL] [Abstract][Full Text] [Related]
16. Biological Therapies for Atopic Dermatitis: A Systematic Review.
Zhou S; Qi F; Gong Y; Zhang J; Zhu B
Dermatology; 2021; 237(4):542-552. PubMed ID: 33735876
[TBL] [Abstract][Full Text] [Related]
17. Safety considerations of systemic Janus kinase inhibitors in atopic dermatitis applications.
Chang PH; Huang SF; Chang PS; Yu Y
J Dermatol; 2021 Nov; 48(11):1631-1639. PubMed ID: 34462967
[TBL] [Abstract][Full Text] [Related]
18. Economic evaluation of a JAK inhibitor compared to a monoclonal antibody for treatment of moderate-to-severe atopic dermatitis from a UK perspective.
Heinz KC; Willems D; Hiligsmann M
J Med Econ; 2022; 25(1):491-502. PubMed ID: 35350959
[TBL] [Abstract][Full Text] [Related]
19. Novel Therapeutic Approaches and Targets for the Treatment of Atopic Dermatitis.
Pescitelli L; Rosi E; Ricceri F; Pimpinelli N; Prignano F
Curr Pharm Biotechnol; 2021; 22(1):73-84. PubMed ID: 32525769
[TBL] [Abstract][Full Text] [Related]
20. Treatment of atopic dermatitis: Recently approved drugs and advanced clinical development programs.
Müller S; Maintz L; Bieber T
Allergy; 2024 Jun; 79(6):1501-1515. PubMed ID: 38186219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
